芬兰的儿科创伤性脑损伤和注意力缺陷/多动症药物治疗:一项基于全国注册的队列研究

Juho Laaksonen1, Ville Ponkilainen2, Julius Möttönen3

  • 1Department of Clinical Medicine, University of Tampere, Tampere, Finland juho.laaksonen@tuni.fi.

BMJ mental health
|August 2, 2024
PubMed
概括

儿科创伤性脑损伤 (pTBI) 显著增加了注意力缺陷/多动症障碍 (ADHD) 药物使用的风险. 这种关联持续长达20年,强调需要主动预防TBI和长期监测患者.

相关概念视频

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
51
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
157